SCHEMBL16995451

SCHEMBL16995451

COc1cc(C(N)=O)ccc1Nc1ncc(Cl)c(N[C@@H]2CCCC[C@H]2NC(C)=O)n1

nearest known ligand 0.69

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 14/20 0.69
▸ MAPK3 P27361 1/20 0.64
▸ INSR P06213 4/20 0.54
▸ ALK Q9UM73 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12826742 0.90 LRRK2 (0.65) LRRK2
SCHEMBL12826443 0.90 LRRK2 (0.70) LRRK2MAPK3INSRALK
SCHEMBL12826706 0.88 EGFR (0.55) LRRK2MAPK3INSRALK
SCHEMBL12826701 0.88 LRRK2 (0.60) LRRK2MAPK3INSRALK
SCHEMBL18857294 0.88 MAPK3 (0.82) LRRK2MAPK3INSRALK
SCHEMBL18857474 0.88 MAPK3 (0.82) LRRK2MAPK3INSRALK
SCHEMBL18857572 0.88 MAPK3 (0.82) LRRK2MAPK3INSRALK
SCHEMBL12826576 0.87 LRRK2 (0.61) LRRK2
SCHEMBL1465782 0.86 LRRK2 (0.59) LRRK2MAPK3INSRALK
SCHEMBL16995435 0.86 PTK2 (0.68) LRRK2ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408752-B1 SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF CANCER BOEHRINGER INGELHEIM INT (DE) 2015-08-12 — — EP disclosed
Send feedback